Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Preparation of Curcumin-Loaded Plga Nanoparticles and Investigation of Its Cytotoxicity Effects on Human Glioblastoma U87mg Cells Publisher



Arzani H1, 2 ; Adabi M1 ; Mosafer J2, 3 ; Dorkoosh F4 ; Khosravani M1 ; Maleki H1 ; Nekounam H1 ; Kamali M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
  3. 3. Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Biointerface Research in Applied Chemistry Published:2019


Abstract

Curcumin, an herbal derivative, could be used as anticancer agent in drug delivery. Due to hydrophobic properties of curcumin, its bioavailability decreases to cancer cells. The aim of this study was to prepare curcumin loaded poly (lactic-co-glycolic acid) nanoparticles (CUR-PLGA-NPs) as a drug delivery system to overcome the limitation of hydrophobicity of CUR as well as to investigate its toxicity effect on human glioblastoma U87MG cells compared to free CUR. Single emulsion method was used to prepare CUR-PLGA-NPs. Under optimum conditions, the size of nanoparticles was characterized by dynamic light scattering (DLS) and scanning electron microscopy (SEM). Encapsulation efficiency and loading content were 89.77% and 9.06 %, respectively; with a biphasic release behavior. Differential scanning calorimetric (DSC) thermograph of CUR-PLGA-NPs exhibited that CUR was dispersed in amorphous phase. The cytotoxicity studies on U87MG cell line indicated that CUR-PLGA-NPs had high cytotoxicity effects compared to free CUR. The half maximal inhibitory concentration (IC50) after cell incubation for 72 h was 57.99 μg/mL and 32.90 μg/mL for free CUR and CUR-PLGA-NPs, respectively. In conclusion, it is suggested that CUR-PLGA-NPs can be used for drug delivert to cancer cells. © 2019 by the authors.
Other Related Docs
15. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma, Biomedicine and Pharmacotherapy (2016)
16. Biomedical Applications of Intelligent Nanomaterials, Intelligent Nanomaterials: Second Edition (2016)
19. Therapeutic Potentials of Curcumin in the Treatment of Glioblstoma, European Journal of Medicinal Chemistry (2020)
22. Vip-Loaded Plga As an Anti-Asthma Nanodrug Candidate, Comparative Clinical Pathology (2016)
27. N-Acetylcysteine-Loaded Plga Nanoparticles Outperform Conventional N-Acetylcysteine in Acute Lung Injuries in Vivo, International Journal of Polymeric Materials and Polymeric Biomaterials (2017)